
AstraZeneca to globally withdraw COVID-19 vaccine amid declining demand
AstraZeneca to globally withdraw COVID-19 vaccine amid declining demand
May 7 (Reuters) – AstraZeneca (AZN.L), opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe.
“As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to media, opens new tab reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.
The firm’s application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
(Except for the headline, this story has not been edited by VoM News staff and is published from syndicated feed)
Latest Posts
- WhatsApp Puts Multiple Accounts ‘Under Review’, Blocks Access For 24 Hours
August 4, 2026 | Breaking News, Social Media - Centre Hikes Windfall Gains Tax On Export Of Petrol, Diesel Amid Iran War
August 4, 2026 | Breaking News, India - NEET Paper Leak Dominates Punjab Assembly Session, AAP Attacks BJP
August 4, 2026 | Breaking News, India, Politics - LIC Stake Sale Begins Tuesday; India Government Launches LIC OFS
August 4, 2026 | Breaking News, Business, India - Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook
August 3, 2026 | Breaking News, Business, Markets - Ukraine Removes US Ambassador Olha Stefanishyna From Post
August 3, 2026 | Breaking News, Politics, World - FSSAI Prohibits Sale of Dabur India Products Carrying Misleading ‘100%’ Claims
August 3, 2026 | Breaking News, Business, India - Citi hires Bank of America’s Rohan Sen to lead technology services banking
August 3, 2026 | Breaking News, World - UBS Fined $125 Million by US Regulators for Anti-Money Laundering Violations
August 3, 2026 | Breaking News, Business, Markets - SAS airline cabin crew in Norway plan to go on strike from August 8
August 3, 2026 | Breaking News, Business, Markets